HRP20170897A2 - Topikalna farmaceutska formulacija na bazi mupirocina kao antivirusno sredstvo - Google Patents

Topikalna farmaceutska formulacija na bazi mupirocina kao antivirusno sredstvo

Info

Publication number
HRP20170897A2
HRP20170897A2 HRP20170897AA HRP20170897A HRP20170897A2 HR P20170897 A2 HRP20170897 A2 HR P20170897A2 HR P20170897A A HRP20170897A A HR P20170897AA HR P20170897 A HRP20170897 A HR P20170897A HR P20170897 A2 HRP20170897 A2 HR P20170897A2
Authority
HR
Croatia
Prior art keywords
mupirocin
viral infections
pharmaceutical formulation
antiviral agent
topical pharmaceutical
Prior art date
Application number
HRP20170897AA
Other languages
English (en)
Inventor
Katica Cepanec
Ivica Cepanec
Original Assignee
Amelia d.o.o.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amelia d.o.o. filed Critical Amelia d.o.o.
Priority to HRP20170897AA priority Critical patent/HRP20170897A2/hr
Publication of HRP20170897A2 publication Critical patent/HRP20170897A2/hr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Predmetni izum otkriva farmaceutske formulacije mupirocina (1) ili njegovih farmaceutski prihvatljivih soli ili estera; kao učinkovitih antivirusnih sredstava za upotrebu u topikalnoj terapiji virusnih infekcija kod ljudi i životinja. Formulacije mupirocina prema izumu posebno su učinkovite u topikalnom tretmanu virusnih infekcija Herpes simplex i Herpes zoster.The subject matter of the invention reveals pharmaceutical formulations based on mupirocin (1) or its pharmaceutically acceptable salts or esters, as efficient antiviral agents to be used in topical therapy of viral infections with humans and animals. Formulations based on mupirocin according to the invention are especially efficient in topical treatment of viral infections Herpes simplex and Herpes zoster.
HRP20170897AA 2017-06-13 2017-06-13 Topikalna farmaceutska formulacija na bazi mupirocina kao antivirusno sredstvo HRP20170897A2 (hr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HRP20170897AA HRP20170897A2 (hr) 2017-06-13 2017-06-13 Topikalna farmaceutska formulacija na bazi mupirocina kao antivirusno sredstvo

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HRP20170897AA HRP20170897A2 (hr) 2017-06-13 2017-06-13 Topikalna farmaceutska formulacija na bazi mupirocina kao antivirusno sredstvo

Publications (1)

Publication Number Publication Date
HRP20170897A2 true HRP20170897A2 (hr) 2018-12-28

Family

ID=64899134

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20170897AA HRP20170897A2 (hr) 2017-06-13 2017-06-13 Topikalna farmaceutska formulacija na bazi mupirocina kao antivirusno sredstvo

Country Status (1)

Country Link
HR (1) HRP20170897A2 (hr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113476435A (zh) * 2021-08-25 2021-10-08 山东省农业科学院畜牧兽医研究所 莫匹罗星在制备抗牛流行热病毒药物中的应用

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113476435A (zh) * 2021-08-25 2021-10-08 山东省农业科学院畜牧兽医研究所 莫匹罗星在制备抗牛流行热病毒药物中的应用

Similar Documents

Publication Publication Date Title
AR116415A2 (es) Composiciones veterinarias orales parasiticidas que comprenden agentes activos de acción sistémica, métodos y usos de las mismas
CL2018000033A1 (es) Composición para destapar una nariz tapada que tiene actividad antiviral.
CL2017002727A1 (es) Composiciones de ácido obeticólico y métodos de uso
CL2015003686A1 (es) Derivados de pirrolo[3,2-d]pirimidina para el tratamiento de infecciones víricas y otras enfermedades
CL2020001762A1 (es) Formas cristalinas del derivado de 4-pirimidinsulfamida de aprocitentán. (divisional solicitud 201902464)
BR112015020118A2 (pt) derivados de 2-aminopirimidina para o tratamento de infecções virais
PH12016500024A1 (en) Bromodomain inhibitor
MX2016002589A (es) Composicion farmaceutica que contiene compuesto de pirimidina como ingrediente activo.
BR112015018087A8 (pt) composto, composição farmacêutica e uso
UY35391A (es) Acido 2-aza-biciclo[2.2.1]heptano-3-carboxilico (bencil-cianometil)-amidas sustituidas inhibidores de catepsina c
CL2022003733A1 (es) Análogos de nucleósido de 1’-ciano y usos de los mismos
PH12016501567A1 (en) 4`-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza rna replication
BR112019001768A2 (pt) moduladores do receptor de spiro-lactamas nmda e usos dos mesmos
BR112019001921A2 (pt) moduladores do receptor nmda de espiro-lactama e seus usos
CO2020010193A2 (es) Una composición farmacéutica para la anemia
WO2011160024A3 (en) Compounds useful as antiviral agents, compositions, and methods of use
PH12020550956A1 (en) Sgc stimulators
BR112015005347A2 (pt) composto, composição farmacêutica, e, método para tratamento ou profilaxia de infecção por hiv ou para tratamento, profilaxia, ou atraso no início de aids
WO2018089328A8 (en) TREATMENT OF CNS DISEASES USING GCS STIMULATORS
PH12019501017A1 (en) Sgc stimulators
MX2017013795A (es) Combinaciones terapeuticas de tratamientos antivirales y antiinflamatorios.
BR112019007591A2 (pt) inibidores de bromodomínios
BR112021009078A8 (pt) Antagonistas substituídos de receptor de adenosina de aminotriazolopirimidina e aminotriazolopirazina, composições farmacêuticas e seus usos
HRP20170897A2 (hr) Topikalna farmaceutska formulacija na bazi mupirocina kao antivirusno sredstvo
CL2018002368A1 (es) Formulaciones de oritavancina

Legal Events

Date Code Title Description
A1OB Publication of a patent application
OBST Application withdrawn